Healthy Adult Subjects clinical trials

Explore recruiting healthy adult subjects clinical trials.

Recruiting healthy adult subjects studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Healthy Adult Subjects trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Pharmacokinetic Study of Single and Multiple Dose of PKL-021 Administered Orally to Healthy Subjects

Czechia

Human Pharmacology (Phase I)- Other EU CTIS Study details

A PHASE 1 STUDY TO ASSESS THE MASS BALANCE, PHARMACOKINETICS, AND METABOLISM OF ORAL [14C]-ZIPALERTINIB IN HEALTHY ADULT MALE SUBJECTS

Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Four Way Crossover Thorough QT/QTc Study to Evaluate the Electrocardiographic Effects of Therapeutic and Supratherapeutic Doses of Cytisinicline in Healthy Smokers

Portugal

Human Pharmacology (Phase I)- Other EU CTIS Study details

Single Dose Crossover Comparative Bioavailability and Food Effect Study of Celecoxib 10 mg/1 mL Oral Suspension versus Celebrex®️ (celecoxib) 200 mg Capsules Following the Administration of a 200 mg Dose in Healthy Adult Volunteers / Fasting and Fed State.

Czechia

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

Evaluation of quantitative sensory testing (QST) using subcutaneous administration of single escalating doses of halneuron® (tetrodotoxin (TTX)) for injection in healthy volunteers

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A Pilot Open-label, Randomized, Crossover, Comparative Bioavailability Study of Levodopa Administered via Levodopa Cyclops™ (test product) Relative to INBRIJA® (reference product) in Healthy Adult Subjects

Bulgaria

Human Pharmacology (Phase I)- Other EU CTIS Study details

Healthy Adult Subjects trials by city

Healthy Adult Subjects in Toronto Healthy Adult Subjects in Vancouver Healthy Adult Subjects in Montreal Healthy Adult Subjects in Calgary Healthy Adult Subjects in Edmonton Healthy Adult Subjects in Ottawa Healthy Adult Subjects in Winnipeg Healthy Adult Subjects in Quebec City Healthy Adult Subjects in Hamilton Healthy Adult Subjects in Kitchener Healthy Adult Subjects in London Healthy Adult Subjects in Halifax Healthy Adult Subjects in New York Healthy Adult Subjects in Los Angeles Healthy Adult Subjects in Chicago Healthy Adult Subjects in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease